Log In
BCIQ
Print this Print this
 

BMS-955176

  Manage Alerts
Collapse Summary General Information
Company ViiV Healthcare Ltd.
DescriptionSecond generation HIV-1 maturation inhibitor
Molecular Target
Mechanism of ActionHIV maturation inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV-1 infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

$1,268.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/18/2015

Undisclosed

Undisclosed

$1,268.0M

Get a free BioCentury trial today